1. Abdelgawad MA, Labib MB, Ali WAM, Kamel G, Azouz AA, El-Nahass ES. (2018) Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
Bioorg Chem, 78: 103-114.
[PMID:29550530]
2. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, Summers JB, Brooks DW. (1991) 5-lipoxygenase inhibitory activity of zileuton.
J Pharmacol Exp Ther, 256 (3): 929-37.
[PMID:1848634]
3. Chaaban I, Rizk OH, Ibrahim TM, Henen SS, El-Khawass EM, Bayad AE, El-Ashmawy IM, Nematalla HA. (2018) Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives.
Bioorg Chem, 78: 220-235.
[PMID:29602046]
4. Cho H, Ueda M, Tamaoka M, Hamaguchi M, Aisaka K, Kiso Y, Inoue T, Ogino R, Tatsuoka T, Ishihara T et al.. (1991) Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase.
J Med Chem, 34 (4): 1503-5.
[PMID:2016727]
5. El-Nagar MKS, Abdu-Allah HHM, Salem OIA, Kafafy AN, Farghaly HSM. (2018) Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
Bioorg Chem, 78: 80-93.
[PMID:29550533]
6. Fischer L, Steinhilber D, Werz O. (2004) Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.
Br J Pharmacol, 142 (5): 861-8.
[PMID:15197110]
7. Garscha U, Romp E, Pace S, Rossi A, Temml V, Schuster D, König S, Gerstmeier J, Liening S, Werner M et al.. (2017) Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase.
Sci Rep, 7 (1): 9398.
[PMID:28839250]
8. Liu Y, Duan C, Chen H, Wang C, Liu X, Qiu M, Tang H, Zhang F, Zhou X, Yang J. (2018) Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation.
Toxicol Appl Pharmacol, 351: 1-11.
[PMID:29763636]
9. Luo M, Jones SM, Phare SM, Coffey MJ, Peters-Golden M, Brock TG. (2004) Protein kinase A inhibits leukotriene synthesis by phosphorylation of 5-lipoxygenase on serine 523.
J Biol Chem, 279 (40): 41512-20.
[PMID:15280375]
10. Masferrer JL, Zweifel BS, Hardy M, Anderson GD, Dufield D, Cortes-Burgos L, Pufahl RA, Graneto M. (2010) Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
J Pharmacol Exp Ther, 334 (1): 294-301.
[PMID:20378715]
11. Nandha B, Ramareddy SA, Kuntal H. (2018) Synthesis of substituted fluorobenzimidazoles as inhibitors of 5-lipoxygenase and soluble epoxide hydrolase for anti-inflammatory activity.
Arch Pharm (Weinheim), 351 (6): e1800030.
[PMID:29732612]
12. P JJ, Manju SL, Ethiraj KR, Elias G. (2018) Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
Eur J Pharm Sci, 121: 356-381.
[PMID:29883727]
13. Payne AN, Jackson WP, Salmon JA, Nicholls A, Yeadon M, Garland LG. (1991) Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
Agents Actions Suppl, 34: 189-99.
[PMID:1793063]
14. Prasher P, Pooja, Singh P. (2014) Lead modification: amino acid appended indoles as highly effective 5-LOX inhibitors.
Bioorg Med Chem, 22 (5): 1642-8.
[PMID:24508141]
15. Schühly W, Hüfner A, Pferschy-Wenzig EM, Prettner E, Adams M, Bodensieck A, Kunert O, Oluwemimo A, Haslinger E, Bauer R. (2009) Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Bioorg Med Chem, 17 (13): 4459-65.
[PMID:19481465]
16. Singh P, Prasher P, Dhillon P, Bhatti R. (2015) Indole based peptidomimetics as anti-inflammatory and anti-hyperalgesic agents: Dual inhibition of 5-LOX and COX-2 enzymes.
Eur J Med Chem, 97: 104-23.
[PMID:25956953]
17. Sinha S, Doble M, Manju SL. (2018) Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
Eur J Med Chem, 158: 34-50.
[PMID:30199704]